acute lymphocytic leukemia

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

Terminated
  • Acute Myelogenous Leukemia
  • +4 more
  • CliniMACS® CD34 Reagent System
  • +5 more
  • New York, New York
    Weill Cornell Medical College
Jun 12, 2018

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)

Completed
  • Acute Myelocytic Leukemia
  • +4 more
  • ON 01910.Na
  • New York, New York
    Mount Sinai Medical Center
Jan 9, 2018

Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia Trial in Hackensack, New York, Chapel Hill (Writing A (Experimental

Completed
  • Leukemia
  • +5 more
  • Writing A (Experimental informative writing)
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Nov 14, 2017